Is Sanofi SA (ADR) (NYSE:SNY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, …
Shares of Sanofi SA (SNYNF,SNY) were gaining around 2 percent in the morning trading in Paris after the French drug giant on Monday lifted its forecast for fiscal 2017, despite reporting weak profit in its second quarter. Net sales, …
Genzyme argued that the drug Lemtrada's market potential was not being recognized in Sanofi's offering price. After months of back and forth, the two sides agreed on a compromise: a tracking stock that allowed investors to make an …
“This is a setback for the company’s most important growth driver of recent years,” said Berenberg analyst Alistair Campbell, who has a “hold” rating on Sanofi stock. Sanofi stuck to its 2014 profit forecast despite weaker-than …
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation (NASDAQ: GENZ). The exchange offer and …
Sanofi and MannKind launched a $925 million partnership in 2014 to market Afrezza, an inhalable form of insulin, shortly after it was approved. (For more, see Is This Diabetes Stock a Better Bet Than MannKind?) At the time, the market for …
Paris, France - June 15, 2017 - Sanofi announced today the launch of "Action 2017", a worldwide stock purchase plan reserved for its employees. In doing such a capital increase, Sanofi intends to better associate its employees with the …
The analyst in Paris also doubted the news would be reflected in Sanofi's stock price. The stock has risen 18.5 percent since the beginning of the year. Sanofi closed today at 372.1 francs, down 3.3 francs, or 0.9 percent.
The company said it plans to buy back shares using some of the cash proceeds of the swap. Sanofi’s stock was up about 5.3 percent during morning trade on the Euronext Paris Stock Exchange. Boehringer is privately owned. The …
Sanofi gets 65% of the profits while MannKind takes in 35% ... Still, investors drove up shares despite those warnings — responsible of late for some discounting of the stock — and regardless of MannKind’s earnings shortfall. The company, …